NCT06569368View on ClinicalTrials.gov

Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy

PHASE2RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2028

Conditions

Rectal Adenocarcinoma

Interventions

DRUG

Metronidazole

Given by PO

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER